Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.09 USD | +4.02% | +1.21% | +30.20% |
Apr. 10 | Baird Raises Owens & Minor's Price Target to $28 From $24, Maintains Neutral Rating | MT |
Feb. 29 | Owens & Minor Insider Sold Shares Worth $250,000, According to a Recent SEC Filing | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.34 for the 2024 fiscal year.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- With an expected P/E ratio at 167.27 and 27.67 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+30.20% | 1.92B | B+ | ||
-3.41% | 9.4B | B+ | ||
-3.90% | 1.39B | D | ||
-7.38% | 1.18B | - | ||
-18.42% | 857M | - | - | |
+0.48% | 470M | - | ||
+3.62% | 437M | - | - | |
-49.68% | 360M | - | ||
-24.72% | 333M | - | - | |
-2.42% | 212M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- OMI Stock
- Ratings Owens & Minor, Inc.